SOMER BABUREK

Somer is the CEO of Hera Biotech developing and commercializing the world’s 1st non-surgical test for definitive diagnosis and staging of endometriosis. An achievement oriented strategic thinker with strong communication, presentation and interpersonal skills. Adept at building and maintaining close relationships with key stakeholders. Ability to work in all levels of an organization with a desire to find opportunities for improvement.